Over the years, numerous scientists have stated to 'successfully produce a Human Immunodeficiency Virus (HIV-1) vaccine, innovative technologies could be required.'
HIV-1 is the most common virus type, has unprecedented genetic variability, and the ability to quickly establish a lifelong infection are just some of the obstacles researchers face in trying to understand how to induce protective immunity against the virus, confirms the International AIDS Vaccine Initiative.
Read More
